Ingen internetforbindelse — viser den gemte version af siden.

Geron Corporation

USUSD
← Til Screeneren

Geron Corporation (LSE:0IV3) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

⚠ Forveksl dem ikke: der findes et andet firma med samme eller et meget lignende navn. Det er en separat registrering — tjek ticker, børs og registreringsnummer.
  • Geron Co Ltd — 002722 · SHE CN Registreringsnummer ukendt

Om Virksomheden

Websted
geron.com
Investorrelationer
ir.geron.com/investor-relations
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
Foster City, United States
Administrerende Direktør
Harout Semerjian
Ansatte
258
Grundlagt
1990
Udestående Aktier
642.47 mio. pr. 2026-07-31
Free Float
556.32 mio.
Markedsværdi
790.24 mio. USD
Insidere
0.08%
Institutionelle Investorer
76.63%
Branche (SIC)
Pharmaceutical Preparations
ISIN
US3741631036
LEI
549300T282D7Z2YESL90
FCF
−115 mio. USD
Gæld
120 mio. USD
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
NAV
0.34 USD · P/NAV 3.67
Balancedato30.06.2026
Aktiver519 mio. USD
− Forpligtelser300 mio. USD
= NAV (aktiekapital i selskabets aktionærer)219 mio. USD
= Materiel NAV219 mio. USD
Aktier642 473 409
NAV pr. Aktie0.34 USD
Håndgribelig NAV pr. Aktie0.34 USD
Aktiekurs (0IV3)1.2500 USD
P/NAV3.67
NAV-Historie
BalancedatoNAVNAV pr. Aktie
30.06.2026219 mio. USD0.34 USD
31.03.2026229 mio. USD0.36 USD
31.12.2025226 mio. USD0.35 USD
30.09.2025249 mio. USD0.39 USD
30.06.2025260 mio. USD0.41 USD
31.03.2025268 mio. USD0.42 USD
31.12.2024280 mio. USD0.46 USD
30.09.2024292 mio. USD0.48 USD
Beskrivelse

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

annonce

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksGERN primærUSD1.23 +3.36%almindelige aktier
LSE London Stock Exchange0IV3 IOBUSD1.25 +0.00%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Største Ejere

EjerAndelAktierRapportdato
Blackrock Inc.7.64%49.12 mio.2026-06-30
RA Capital Management, L…6.66%42.81 mio.2026-06-30
Soleus Capital Managemen…6.66%42.81 mio.2026-06-30
State Street Corporation5.58%35.86 mio.2026-06-30
Citadel Advisors Llc4.52%29.04 mio.2026-06-30
Vanguard Capital Managem…4.24%27.25 mio.2026-06-30
SPDR SERIES TRUST-State…3.58%23.03 mio.2026-08-31
VANGUARD INDEX FUNDS-Van…3.18%20.45 mio.2026-06-30
ClearBridge Investments,…3.06%19.65 mio.2026-06-30
Eversept Partners, LP2.91%18.72 mio.2026-06-30
Goldman Sachs Group Inc2.59%16.63 mio.2026-06-30
Geode Capital Management…2.27%14.56 mio.2026-06-30
iShares Trust-iShares Ru…2.22%14.26 mio.2026-08-31
Vanguard Explorer Fund2.02%12.98 mio.2026-07-31
Legg Mason Partners Inve…0.98%6.32 mio.2026-07-31
VANGUARD INDEX FUNDS-Van…0.95%6.11 mio.2026-06-30
Fidelity Salem Street Tr…0.95%6.1 mio.2026-07-31
Fidelity Select Portfoli…0.85%5.45 mio.2026-07-31
iShares Trust-iShares Ru…0.81%5.18 mio.2026-08-31
iShares Trust-iShares Bi…0.73%4.67 mio.2026-08-31
SPIEGEL ROBERT J (Direct…≈0.03%205 8102026-06-30
SCARLETT JOHN A (Chief E…≈0.02%137 5002025-02-27
ZIEGLER JAMES (Officer)≈0.02%100 0002025-02-27
SAMUELS SCOTT ALAN (Offi…≈0%26 6822025-02-27
ROBERTSON MICHELLE (Chie…≈0%17 6452026-02-18
LAWLIS VIRGIL BRYAN JR.…≈0%13 3002025-05-09